Does CAPMATINIB Cause Swelling? 59 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Swelling have been filed in association with CAPMATINIB (TABRECTA). This represents 2.6% of all adverse event reports for CAPMATINIB.
59
Reports of Swelling with CAPMATINIB
2.6%
of all CAPMATINIB reports
1
Deaths
11
Hospitalizations
How Dangerous Is Swelling From CAPMATINIB?
Of the 59 reports, 1 (1.7%) resulted in death, 11 (18.6%) required hospitalization, and 1 (1.7%) were considered life-threatening.
Is Swelling Listed in the Official Label?
Yes, Swelling is listed as a known adverse reaction in the official FDA drug label for CAPMATINIB.
What Other Side Effects Does CAPMATINIB Cause?
Death (411)
Peripheral swelling (283)
Fatigue (257)
Oedema peripheral (247)
Nausea (240)
Malignant neoplasm progression (178)
Dyspnoea (141)
Oedema (130)
Asthenia (113)
Non-small cell lung cancer (96)
What Other Drugs Cause Swelling?
ADALIMUMAB (10,906)
METHOTREXATE (10,702)
ETANERCEPT (10,467)
TOCILIZUMAB (9,420)
ABATACEPT (9,226)
LEFLUNOMIDE (8,885)
RITUXIMAB (8,477)
PREDNISONE (7,968)
HYDROXYCHLOROQUINE (7,937)
CERTOLIZUMAB PEGOL (7,748)
Which CAPMATINIB Alternatives Have Lower Swelling Risk?
CAPMATINIB vs CAPREOMYCIN
CAPMATINIB vs CAPSAICIN
CAPMATINIB vs CAPTOPRIL
CAPMATINIB vs CARBAMAZEPINE
CAPMATINIB vs CARBETOCIN